You are here: All Products  > Fosun Kite Approved to Launch CAR-T as Second Line Therapy for B-Cell Lymphoma

Fosun Kite Approved to Launch CAR-T as Second Line Therapy for B-Cell Lymphoma

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products